Anebulo Pharmaceuticals, Inc. (ANEB) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$8.48M | -3.5% |
| 2024 | -$8.20M | +30.1% |
| 2023 | -$11.73M | -71.9% |
| 2022 | -$6.83M | +77.4% |
| 2021 | -$30.25M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$8.48M | -3.5% |
| 2024 | -$8.20M | +30.1% |
| 2023 | -$11.73M | -71.9% |
| 2022 | -$6.83M | +77.4% |
| 2021 | -$30.25M | — |